首都医科大学学报 ›› 2012, Vol. 33 ›› Issue (2): 255-258.doi: 10.3969/j.issn.1006-7795.2012.02.025

• 临床研究 • 上一篇    下一篇

急性脑梗死患者血清淀粉样蛋白A的临床和预后价值

吴修信, 李立新, 廖品君, 苑媛   

  1. 广东省惠州市第三人民医院神经内科,惠州 516002
  • 收稿日期:2011-10-11 修回日期:1900-01-01 出版日期:2012-04-21 发布日期:2012-04-21

Clinical and prognostic value of serum amyloid A in patients with acute ischemic stroke

WU Xiu-xin, LI Li-xin, LIAO Pin-jun, YUAN Yuan   

  1. Department of Neurology, the Third People's Hospital, Huizhou 516002, China
  • Received:2011-10-11 Revised:1900-01-01 Online:2012-04-21 Published:2012-04-21

摘要: 目的 探讨急性脑梗死患者血清淀粉样蛋白A(serum amyloid A,SAA)的临床和预后价值。方法 选取广东省惠州市第三人民医院神经内科2009年10月1日至2010年10月1日收治的100例急性脑梗死患者,收集其静脉血样本作为病例组,酶联免疫吸附法测定患者治疗前和治疗21 d时SAA浓度,放射免疫比浊法测定C-反应蛋白(C-reactive protein,CRP)浓度;选择50例正常体检者作为对照组。予患者综合治疗,并在入院及治疗21 d时进行美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS) 评分,判断其神经功能缺损情况,利用Pearson相关系数对SAA浓度与NIHSS评分进行分析,探究SAA在急性脑梗死患者中的临床和预后价值。结果 病例组治疗前SAA浓度为(18.05±6.77)mg/L,明显高于治疗后(7.81±2.66)mg/L及对照组(7.49±4.49)mg/L(P均<0.05);病例组治疗前CRP浓度为(15.08±4.32)mg/L,明显高于治疗后(6.05±2.20)mg/L及对照组(5.5±3.34)mg/L(P均<0.05)。21 d时病例组NIHSS评分比入院时明显下降(11.07±4.2 vs 7.78±2.89,P<0.05)。急性脑梗死患者急性期SAA浓度,而非CRP浓度,与NIHSS 评分差值呈正相关(r=0.612,P<0.05)。结论 急性脑梗死患者血清SAA、CRP浓度均明显升高,可作为判断病情活动的重要指标,急性期SAA浓度与治疗前后NIHSS 差值显著相关,提示SAA可作为判断急性脑梗死患者的预后的指标。

关键词: 急性脑梗死, 血清淀粉样蛋白A, C-反应蛋白, 美国国立卫生研究院卒中量表评分

Abstract: Objective To investigate the clinical and prognostic value of serum amyloid A(SAA) in patients with acute ischemic stroke. Methods Blood samples were collected from the patients within the 24 h after admission. Enzyme-linked immunosorbent assay(ELISA) was used to determinate SAA levels among 100 cases of acute stroke patients before and after 21-day treatment and CRP was detected by immunoturbidimetry. Fifty healthy volunteers served as the control group. All patients were given comprehensive treatment. On admission and after 21-day treatment, the National Institutes of Health Stroke Scale(NIHSS) was employed to provide a quantitative measure of stroke-related neurologic deficit. Furthermore, correlation between SAA levels and change in NIHSS score before and after treatment was analyzed using the Pearson correlation coefficient in order to explore the association of SAA levels with clinical picture and prognostic value in patients with acute cerebral infarction. Results SAA levels were significantly higher in acute cerebral infarction patients before treatment(18.05±6.77) mg/L than in the patients after treatment(7.81±2.66) mg/L and in the control group(7.49±4.49) mg/L, respectively(P<0.01). CRP levels were significantly higher in acute cerebral infarction patients before treatment (15.05±4.32) mg/L than in the patients after treatment(6.05±2.20) and in the control group(5.5±3.34) mg/L, respectively(P<0.01). After treatment, NIHSS score decreased significantly at 21 d (11.07±4.2 vs 7.78±2.89, P<0.05). The SAA levels at the acute stage showed a positive correlation with the net change in NIHSS score(r=0.612, P<0.05). Conclusion Patients with acute cerebral infarction have significantly increased SAA and CRP levels, which both indicate active disease. The SAA levels, but not CRP levels, are positively correlated with the net change in NIHSS score, suggesting that SAA may predict the prognosis of patients with acute cerebral infarction and has better prognostic value than CRP.

Key words: acute cerebral infarction, serum amyloid A, C-reactive protein, National Institutes of Health Stroke Scale(NIHSS)

中图分类号: